Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Cash flows from operating activities    
Net loss attributable to common stockholders $ (389,319) $ (372,692)
Adjustments to reconcile net loss to net cash used in operating activities:    
Use of restricted cash and cash equivalents for certain operating activities 102,851 72,785
Loss on early extinguishment of debt 114,335 80,510
Depreciation 48,962 45,533
Amortization of debt issuance costs and discount 10,971 8,590
Stock-based compensation 84,449 202,785
Non-cash LNG inventory write-downs 23,505 27,851
Total (gains) losses on derivatives, net 89,286 (55,706)
Net cash from settlement of derivative instruments (19,745) 653
Net loss attributable to non-controlling interest (118,536) (38,323)
Other (1,975) (2,622)
Changes in operating assets and liabilities:    
Accounts and interest receivable (18,899) (21,514)
Accounts payable and accrued liabilities 62,797 62,502
LNG inventory (26,908) (29,071)
Deferred revenue (2,955) (2,955)
Prepaid expenses and other 131 (629)
Net cash used in operating activities (41,050) (22,303)
Cash flows from investing activities    
Property, plant and equipment, net (2,047,957) (2,448,749)
Use of restricted cash and cash equivalents for the acquisition of property, plant and equipment 1,980,436 2,470,725
Investment in Cheniere Partners 0 (11,122)
Other (24,113) (30,524)
Net cash used in investing activities (91,634) (19,670)
Cash flows from financing activities    
Proceeds from issuances of long-term debt 2,584,500 3,504,478
Proceeds from sale of common units by Cheniere Partners 0 364,775
Investment in restricted cash and cash equivalents (2,254,733) (3,146,006)
Debt issuance and deferred financing costs (94,220) (271,979)
Distributions to non-controlling interest (59,478) (50,046)
Repayments of long-term debt (177,000) (100,000)
Payments related to tax withholdings for stock-based compensation (44,516) (89,137)
Proceeds from exercise of stock options 9,502 274
Other (557) 2,067
Net cash provided by (used in) financing activities (36,502) 214,426
Net increase (decrease) in cash and cash equivalents (169,186) 172,453
Cash and cash equivalents—beginning of period 960,842 201,711
Cash and cash equivalents—end of period $ 791,656 $ 374,164